Omnicell Inc (OMCL)
Return on equity (ROE)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 12,531 | -20,371 | 5,648 | 77,849 | 32,194 |
| Total stockholders’ equity | US$ in thousands | 1,243,310 | 1,188,950 | 1,130,140 | 1,146,690 | 967,503 |
| ROE | 1.01% | -1.71% | 0.50% | 6.79% | 3.33% |
December 31, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $12,531K ÷ $1,243,310K
= 1.01%
Omnicell Inc's return on equity (ROE) has fluctuated over the years based on the provided data.
- In 2020, the ROE was 3.33%, indicating that for every dollar of shareholder equity, the company generated a profit of 3.33 cents.
- By the end of 2021, the ROE had increased to 6.79%, showing an improvement in the company's ability to generate profit from shareholders' equity.
- However, the ROE took a significant dip in 2022, dropping to 0.50% which suggests a lower profitability relative to shareholder investment.
- The trend continued in 2023 with a negative ROE of -1.71%, indicating that the company's net income was insufficient to cover the equity invested by shareholders.
- In 2024, there was a slight improvement in the ROE to 1.01%, but it remained relatively low compared to previous years.
Overall, Omnicell Inc's ROE has been inconsistent, with fluctuations that may be indicative of changes in profitability and efficiency in utilizing shareholder funds. It would be important for the company to analyze the underlying factors contributing to these fluctuations and take necessary actions to improve ROE in the future.
Peer comparison
Dec 31, 2024